Prevalence and Cause of Loss of Visual Acuity and Visual Field in Highly Myopic Eyes: The Beijing Eye Study.
Jonas Jost B, Jonas Rahul A, Xu Jie, Wang Ya Xing
AI Summary
This study found myopic macular degeneration (MMD) was the leading cause of vision loss in highly myopic eyes, but optic neuropathy significantly contributed, especially in extreme myopia, highlighting diverse causes needing careful assessment.
Abstract
Purpose
To explore the prevalence and causes of loss of visual acuity and visual field in highly myopic eyes.
Design
Population-based study.
Participants
4439 subjects of the Beijing Eye Study underwent ophthalmological and systemic examinations including frequency doubling technology perimetry.
Methods
High myopia was defined by a refractive error of ≤-6 diopters (D) or axial length >26.0 mm.
Main outcome measures
Prevalence of vision impairment causes.
Results
212 highly myopic eyes from 154 participants were included with a mean age of 56.2 ± 9.6 years, a mean refractive error of -9.87 ± 3.70 D and a mean axial length of 27.2 ± 1.3 mm. We observed moderate/severe vision impairment (MSVI) in 40 eyes (18.9%; 95% confidence interval [CI], 13.6-24.2) and blindness in 10 eyes (4.7%; 95% CI, 1.8-7.6). Primary causes for MSVI and blindness were myopic macular degeneration (MMD) (29/50; 58%), age-related macular degeneration (1/50; 2%), and branch macular retinal vein occlusion (1/50; 2%). Secondary causes were MMD (4/50; 8%) and optic nerve atrophy (14/50, 28%), further differentiated into non-glaucomatous optic atrophy (NGOA) (9/50; 18%) and glaucomatous optic atrophy (GOA) (5/50; 10%). Prevalence of MMD as vision impairment cause increased significantly from 1/61 (1.6%) in the refractive error group of -6.00 to ≥-7.00 D, to 16/25 (64%) in the group of <-15.0 D. Higher MMD prevalence correlated with higher myopic refractive error (P < 0.001) and increased likelihood of concomitant optic neuropathy (P < 0.001). Similarly, prevalence of optic neuropathy as vision impairment cause increased from 0/61 (0%) in the refractive error group of -6.00 D to ≥-7.00 D, to 9/25 (36%) in the group of <-15.0 D. Higher optic neuropathy prevalence correlated with more myopic refraction (P < 0.001) and older age (P = 0.02).
Conclusions
In this population-based recruited cohort of highly myopic patients, optic neuropathy accounted for vision impairment in 9.0% eyes, which was lower than the prevalence of MMD as vision impairment cause (18.9%). Notably, optic neuropathy became a significant contributor to vision impairment in more advanced high myopia, reaching 36% in the group with refractive error of <-15.0 D.
Financial disclosure(s): Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
MeSH Terms
Shields Classification
Key Concepts5
In a population-based study of 212 highly myopic eyes from 154 participants, moderate/severe vision impairment (MSVI) was observed in 40 eyes (18.9%; 95% confidence interval [CI], 13.6-24.2) and blindness in 10 eyes (4.7%; 95% CI, 1.8-7.6).
Myopic macular degeneration (MMD) was the primary cause for moderate/severe vision impairment (MSVI) and blindness in 29 out of 50 eyes (58%) in a cohort of highly myopic eyes.
Optic nerve atrophy accounted for vision impairment in 14 out of 50 eyes (28%), further differentiated into non-glaucomatous optic atrophy (NGOA) (9/50; 18%) and glaucomatous optic atrophy (GOA) (5/50; 10%), as a secondary cause in highly myopic eyes.
The prevalence of myopic macular degeneration (MMD) as a vision impairment cause increased significantly from 1/61 (1.6%) in the refractive error group of -6.00 to ≥-7.00 D to 16/25 (64%) in the group of <-15.0 D in highly myopic eyes (P < 0.001).
The prevalence of optic neuropathy as a vision impairment cause increased from 0/61 (0%) in the refractive error group of -6.00 D to ≥-7.00 D to 9/25 (36%) in the group of <-15.0 D in highly myopic eyes, correlating with more myopic refraction (P < 0.001) and older age (P = 0.02).
Related Articles5
Ophthalmic and Systemic Factors of Acute Nonarteritic Anterior Ischemic Optic Neuropathy in the Quark207 Treatment Trial.
Randomized Controlled TrialOptic neuropathy in high myopia: Glaucoma or high myopia or both?
ReviewVisual outcome including visual field defects after treatment of paediatric optic pathway glioma: A nationwide cohort study.
Cohort StudyAsymptomatic idiopathic intracranial hypertension: Prevalence and prognosis.
Cohort StudyClinical Characteristics and Stage at Presentation of Glaucoma Patients in Sub-Saharan Africa.
Cross-Sectional StudyIs this article assigned to the wrong chapter(s)? Let us know.